| Purpose | AGM Date | Announcement Date |
|---|---|---|
| AGM | 29 Sep 2026 | 31 Jul 2026 |
| The 38th Annual General Meeting (AGM) of the company for the Financial Year 2025-26, is scheduled to be held on Wednesday, 23rd September, 2026 through Video Conference or Other Audio-Visual Means as per the Circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. Change in the date of 38th AGM of the Company from 23rd September, 2026 to 29th September, 2026. (As per BSE announcement dated on : 27.08.2026) Proceedings of the Annual General Meeting of the Company (As Per BSE Announcement Dated on:29.09.2026). Postal Ballot-Scrutinizers Report (As per BSE announcement dated on : 30.09.2026) | ||
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
